
Global & New Zealand Laparoscopic Devices Market to 2031
Description
New Zealand’s laparoscopic devices market is experiencing steady growth, largely fueled by the increasing use of minimally invasive surgical techniques across multiple medical specialties. The rising preference for laparoscopy is driven by its numerous advantages, such as shorter hospital stays, less postoperative discomfort, quicker recovery, and lower infection risks.
Laparoscopic procedures are becoming the standard in several surgical domains. In bariatric surgery, although New Zealand-specific figures for 2023 are limited, trends similar to neighboring Australia—where 15,985 primary bariatric surgeries were performed, with sleeve gastrectomy representing 80% and low complication rates (1.5% within 90 days)—suggest that New Zealand continues to rely heavily on laparoscopic approaches due to their proven benefits.
Robotic-assisted surgery in general surgical procedures has also gained momentum. Since the first recorded robotic general surgery case in 2014, usage of the da Vinci system in private New Zealand hospitals has grown significantly. Between 2007 and 2022, there were 4,709 such operations, rising from 110 in 2008 to 743 in 2022—reflecting nearly a sevenfold increase and a growing embrace of high-precision, minimally invasive technology. Common laparoscopic procedures, such as appendicectomy and Nissen fundoplication, are routinely performed in pediatric cases, with open appendicectomies becoming increasingly rare since 2000. In colorectal surgery, laparoscopic colectomy is widely utilized for treating colorectal cancer, offering accurate tumor excision with less tissue damage and quicker postoperative bowel function restoration.
Demographic data from public hospitals reveals that laparoscopic surgeries are widely distributed across age and sex groups, with higher rates among women—especially during their reproductive years. For example, in the 30–34 age bracket, 197 laparoscopic procedures were performed on females compared to 30 on males, demonstrating the broad applicability of these procedures across different patient segments.
The market is further driven by continual technological innovation, including advancements in imaging systems, surgical instrumentation, and the expansion of robotic-assisted technologies, all of which contribute to improved outcomes and faster recoveries. Major players in New Zealand’s laparoscopic access instruments sector include Medtronic, Ethicon, Olympus, and Applied Medical Resources, all of whom play a vital role in advancing minimally invasive surgical care in the country.
Laparoscopic procedures are becoming the standard in several surgical domains. In bariatric surgery, although New Zealand-specific figures for 2023 are limited, trends similar to neighboring Australia—where 15,985 primary bariatric surgeries were performed, with sleeve gastrectomy representing 80% and low complication rates (1.5% within 90 days)—suggest that New Zealand continues to rely heavily on laparoscopic approaches due to their proven benefits.
Robotic-assisted surgery in general surgical procedures has also gained momentum. Since the first recorded robotic general surgery case in 2014, usage of the da Vinci system in private New Zealand hospitals has grown significantly. Between 2007 and 2022, there were 4,709 such operations, rising from 110 in 2008 to 743 in 2022—reflecting nearly a sevenfold increase and a growing embrace of high-precision, minimally invasive technology. Common laparoscopic procedures, such as appendicectomy and Nissen fundoplication, are routinely performed in pediatric cases, with open appendicectomies becoming increasingly rare since 2000. In colorectal surgery, laparoscopic colectomy is widely utilized for treating colorectal cancer, offering accurate tumor excision with less tissue damage and quicker postoperative bowel function restoration.
Demographic data from public hospitals reveals that laparoscopic surgeries are widely distributed across age and sex groups, with higher rates among women—especially during their reproductive years. For example, in the 30–34 age bracket, 197 laparoscopic procedures were performed on females compared to 30 on males, demonstrating the broad applicability of these procedures across different patient segments.
The market is further driven by continual technological innovation, including advancements in imaging systems, surgical instrumentation, and the expansion of robotic-assisted technologies, all of which contribute to improved outcomes and faster recoveries. Major players in New Zealand’s laparoscopic access instruments sector include Medtronic, Ethicon, Olympus, and Applied Medical Resources, all of whom play a vital role in advancing minimally invasive surgical care in the country.
Table of Contents
120 Pages
- 1. Introduction
- 1.1Report Guidance
- 1.2Market Segmentation
- 2.Executive Summary
- 2.1Key Insights
- 3.Research Methodology
- 3.1Secondary Research
- 3.2Primary Research
- 3.2.1Data Triangulation and Validation:
- 4. New Zealand Laparoscopic Devices Market Landscape
- 4.1Overview
- 4.2Ecosystem Analysis
- 4.2.1List of Vendors in the Value Chain
- 5. Laparoscopic Devices Market Key Market Dynamics
- 5.1 Laparoscopic Devices Market – Key Market Dynamics
- 5.2Market Drivers
- 5.3Market Restraints
- 5.4Market Opportunities
- 5.5Future Trends
- 5.6Impact of Drivers and Restraints
- 6. New Zealand Laparoscopic Devices Market – Analysis
- 6.1 New Zealand Laparoscopic Devices Market Revenue (US$ Million), 2021–2031
- 6.2 New Zealand Laparoscopic Devices Market Revenue and Forecast Analysis
- 7. New Zealand Laparoscopic Devices Market Analysis – by Product
- 7.1 New Zealand Laparoscopic Devices Market – Revenue and Forecast, 2021–2031 (US$ Million) – by Product
- 8. New Zealand Laparoscopic Devices Market Analysis – by Application
- 8.1 New Zealand Laparoscopic Devices Market – Revenue and Forecast, 2021–2031 (US$ Million) – by Application
- 9. New Zealand Laparoscopic Devices Market Analysis – by End User
- 9.1 New Zealand Laparoscopic Devices Market – Revenue and Forecast, 2021–2031 (US$ Million) – by End User
- 10. Competitive Landscape
- 10.1 Heat Map Analysis by Key Players
- 10.1 Company Positioning and Concentration
- 11. Industry Landscape
- 11.1 Overview
- 11.2 Market Initiative
- 11.2 Partnerships and Collaborations
- 11.2 Other Developments
- 12. Company Profiles
- 12.1 Medtronic Plc
- 12.1. 1 Key Facts
- 12.1. 2 Business Description
- 12.1. 3 Products and Services
- 12.1. 4 Financial Overview
- 12.1. 5 SWOT Analysis
- 12.1. 6 Key Developments
- 12.2 Johnson & Johnson
- 12.2. 1 Key Facts
- 12.2. 2 Business Description
- 12.2. 3 Products and Services
- 12.2. 4 Financial Overview
- 12.2. 5 SWOT Analysis
- 12.2. 6 Key Developments
- 12.3 Olympus Corp
- 12.3. 1 Key Facts
- 12.3. 2 Business Description
- 12.3. 3 Products and Services
- 12.3. 4 Financial Overview
- 12.3. 5 SWOT Analysis
- 12.3. 6 Key Developments
- 12.4 Stryker Corp
- 12.4. 1 Key Facts
- 12.4. 2 Business Description
- 12.4. 3 Products and Services
- 12.4. 4 Financial Overview
- 12.4. 5 SWOT Analysis
- 12.4. 6 Key Developments
- 12.5 Karl Storz SE & Co KG
- 12.5. 1 Key Facts
- 12.5. 2 Business Description
- 12.5. 3 Products and Services
- 12.5. 4 Financial Overview
- 12.5. 5 SWOT Analysis
- 12.5. 6 Key Developments
- 12.6 Boston Scientific Corp
- 12.6. 1 Key Facts
- 12.6. 2 Business Description
- 12.6. 3 Products and Services
- 12.6. 4 Financial Overview
- 12.6. 5 SWOT Analysis
- 12.6. 6 Key Developments
- 12.7 B Braun SE
- 12.7. 1 Key Facts
- 12.7. 2 Business Description
- 12.7. 3 Products and Services
- 12.7. 4 Financial Overview
- 12.7. 5 SWOT Analysis
- 12.7. 6 Key Developments
- 12.8 Smith & Nephew Plc
- 12.8. 1 Key Facts
- 12.8. 2 Business Description
- 12.8. 3 Products and Services
- 12.8. 4 Financial Overview
- 12.8. 5 SWOT Analysis
- 12.8. 6 Key Developments
- 12.9 Conmed Corp
- 12.9. 1 Key Facts
- 12.9. 2 Business Description
- 12.9. 3 Products and Services
- 12.9. 4 Financial Overview
- 12.9. 5 SWOT Analysis
- 12.9. 6 Key Developments
- 12.10 Intuitive Surgical Inc
- 12.10. 1 Key Facts
- 12.10. 2 Business Description
- 12.10. 3 Products and Services
- 12.10. 4 Financial Overview
- 12.10. 5 SWOT Analysis
- 12.10. 6 Key Developments
- 13. Appendix
- 13.1 About Business Market Insights
- 13.2 List of Abbreviations
- TABLE OF TABLES
- Table 1. New Zealand Laparoscopic Devices Market Segmentation
- Table 2. List of Vendors
- Table 3. New Zealand Laparoscopic Devices Market – Revenue, 2021–2024 (US$ Million)
- Table 4. New Zealand Laparoscopic Devices Market – Revenue Forecast, 2025–2031 (US$ Million)
- Table 5. New Zealand Laparoscopic Devices Market – Revenue, 2021–2024 (US$ Million) – by Product
- Table 6. New Zealand Laparoscopic Devices Market – Revenue Forecast, 2025–2031 (US$ Million) – by Product
- Table 7. New Zealand Laparoscopic Devices Market – Revenue, 2021–2024 (US$ Million) – by Application
- Table 8. New Zealand Laparoscopic Devices Market – Revenue Forecast, 2025–2031 (US$ Million) – by Application
- Table 9. New Zealand Laparoscopic Devices Market – Revenue, 2021–2024 (US$ Million) – by End User
- Table 10. New Zealand Laparoscopic Devices Market – Revenue Forecast, 2025–2031 (US$ Million) – by End User
- Table 11. List of Abbreviations
- TABLE OF FIGURES
- Figure 1. Impact Analysis of Drivers and Restraints
- Figure 2. New Zealand Laparoscopic Devices Market Revenue, (US$ Million), 2021–2031
- Figure 3. Heat Map Analysis by Key Players
- Figure 4. Company Positioning and Concentration
Search Inside Report
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.